BOOSTING ONCOLOGY INVESTIGATION WITH BUILT-IN KRAS ASSAY SOLUTIONS AND RAS ASSAYS

inside the promptly evolving field of oncology analysis, correct and productive mutation screening is essential for developing targeted therapies. The KRAS companies Platform plays a pivotal position During this landscape by giving in depth answers for KRAS mutation profiling and analysis. KRAS mutations, present in close to ninety five% of RAS-sim